Mettler-Toledo International’s (MTD) Neutral Rating Reaffirmed at Bank of America

Bank of America reiterated their neutral rating on shares of Mettler-Toledo International (NYSE:MTD) in a research note issued to investors on Tuesday morning, Briefing.com Automated Import reports. They currently have a $755.00 target price on the medical instruments supplier’s stock, up from their prior target price of $725.00.

Other analysts have also issued reports about the stock. Zacks Investment Research raised shares of Mettler-Toledo International from a hold rating to a buy rating and set a $742.00 price objective for the company in a research note on Tuesday, February 12th. ValuEngine raised shares of Mettler-Toledo International from a hold rating to a buy rating in a research note on Thursday, January 24th. Finally, Evercore ISI lowered shares of Mettler-Toledo International from an in-line rating to an underperform rating in a research note on Thursday, January 3rd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the company. The stock currently has an average rating of Hold and a consensus price target of $650.67.

Shares of MTD opened at $732.17 on Tuesday. The firm has a market cap of $18.49 billion, a PE ratio of 36.03, a P/E/G ratio of 2.64 and a beta of 1.35. Mettler-Toledo International has a 12-month low of $500.74 and a 12-month high of $750.00. The company has a quick ratio of 1.06, a current ratio of 1.42 and a debt-to-equity ratio of 1.67.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 7th. The medical instruments supplier reported $6.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $6.74 by $0.11. The firm had revenue of $817.92 million during the quarter, compared to analyst estimates of $807.58 million. Mettler-Toledo International had a net margin of 17.46% and a return on equity of 94.57%. The business’s revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the firm earned $5.97 earnings per share. Analysts predict that Mettler-Toledo International will post 22.66 EPS for the current year.

In other news, insider Gerry Keller sold 250 shares of the company’s stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $664.50, for a total transaction of $166,125.00. Following the transaction, the insider now owns 404 shares in the company, valued at $268,458. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Robert F. Spoerry sold 35,000 shares of the company’s stock in a transaction dated Thursday, February 21st. The shares were sold at an average price of $672.50, for a total transaction of $23,537,500.00. Following the transaction, the director now owns 5,894 shares in the company, valued at approximately $3,963,715. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 150,995 shares of company stock valued at $100,997,450. 3.50% of the stock is owned by insiders.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Palisade Asset Management LLC acquired a new position in shares of Mettler-Toledo International during the first quarter valued at about $1,164,000. Virtu Financial LLC increased its holdings in shares of Mettler-Toledo International by 64.6% during the first quarter. Virtu Financial LLC now owns 1,634 shares of the medical instruments supplier’s stock valued at $1,181,000 after acquiring an additional 641 shares in the last quarter. Murphy Capital Management Inc. acquired a new position in shares of Mettler-Toledo International during the first quarter valued at about $216,000. Bell Asset Management Ltd increased its holdings in shares of Mettler-Toledo International by 19.2% during the first quarter. Bell Asset Management Ltd now owns 10,925 shares of the medical instruments supplier’s stock valued at $7,899,000 after acquiring an additional 1,760 shares in the last quarter. Finally, Moody National Bank Trust Division increased its holdings in shares of Mettler-Toledo International by 19.8% during the first quarter. Moody National Bank Trust Division now owns 145 shares of the medical instruments supplier’s stock valued at $105,000 after acquiring an additional 24 shares in the last quarter. Hedge funds and other institutional investors own 95.69% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; metal detection and other end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries; and solutions that are used in various process analytics applications.

See Also: Quiet Period Expirations

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.